2022 Revenues ($USD) : $17,108,000,000
2022 R&D spend : $1,235,000,000
2022 Number of Employees : 46,000
Fiscal Year End : 12/31/2021
Company CEO : Kevin Lobo, chair, president and CEO
Despite increased competition in the robotic orthopedic surgery space from J&J’s DePuy Synthes, Zimmer Biomet and Smith+Nephew, Stryker is still enjoying increased Mako sales. Mako sales were up 19% year-over-year in Q2 2022 –CN